Large-scale study of brain volume found genetic links to Parkinson’s disease and ADHD
On Oct. 21, 2024, in one of the largest-ever studies of DNA and brain volume, researchers announced they…
Amneal Launched CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules for Treatment of Parkinson’s Disease
On Sept. 30, 2024, Amneal Pharmaceuticals announced that it had launched CREXONT ® (carbidopa and levodopa) extended-release capsules…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | Non-Profit Research | Therapeutics
New mutation linked to early-onset Parkinsonism
On Sept. 26. 2024, a team of scientists led by Prof. Patrik Verstreken at the VIB-KU Leuven Center…
Study found no link between migraine and Parkinson’s disease
On Aug. 21, 2024, Contrary to previous research, a new study of female participants finds no link between…
Amneal Received U.S. FDA Approval for IPX203 for Treatment of Parkinson’s Disease
On Aug. 7, 2024, Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) had approved CREXONT…
Biotechnology | Diagnostics | Infectious Disease | Life Science News | Medicine | Neurology | Non-Profit Research | Oncology | Therapeutics
CIRM awarded $53 million to clinical research in heart failure and cystic fibrosis, supporting 10 translational projects
On May 30, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had awarded $53 million to…
Findings from 23andMe research on Parkinson’s disease published in Brain
On May 29, 2024, 23andMe with support from The Michael J. Fox Foundation for Parkinson’s Research, announced it…
Milestones in Parkinson’s
Milestones in Parkinson’s illustrates advancements in the disease from James Parkinson’s essay on ‘shaking palsy’ to development of…
First-in-human implant of ‘closed-loop’ bioelectronic research system begun for Parkinson’s-like Multiple Systems Atrophy
On Feb. 8, 2022, researchers at Oxford University announced they had implanted a novel closed-loop research platform for…
UPenn researchers received a $20 million NIH grant to develop a critical tool for imaging Parkinson’s and other diseases
On Oct. 10, 2019, UPenn researchers announced they had received a $20 million National Institutes of Health (NIH)…
Adamas announced FDA approval of GOCOVRI as first and only medication fortreatment of Dyskinesia in Parkinson’s disease Patients
On Aug. 24, 2017, Adamas announced U.S. Food and Drug Administration (FDA) approval of GOCOVRI as First and…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | Non-Profit Research | Therapeutics
The Kavli Foundation awarded $20 million to establish the Kavli Neural Systems Institute at The University of California, San Francisco
On Oct. 1, 2015, The Kavli Foundation announced a $20 million award to establish the Institute for Fundamental…
Biotechnology | Diagnostics | Life Science News | Medical Device | Medicine | Non-Profit Research | Pharmaceutical | Therapeutics
Keck School of Medicine of USC established USC Alzheimer’s Therapeutic Research Institute
On Jun. 26, 2015, The Keck School of Medicine announced it had established the University of Southern California…
Tretiakoff first used the term ‘corps de Lewy’ (Lewy bodies)
In 1919, Konstantin Tretiakoff first used the term ‘corps de Lewy’ (Lewy bodies) and reported the presence of…